|
Active substance |
Adalimumab |
|
Holder |
AbbVie sa/nv |
|
Status |
Closed |
|
Indication |
Treatment of non-infectious intermediate, posterior and pan-uveitis |
|
Public documents |
|
|
Last update |
08/09/2017 |
Humira®
Last updated on 15/09/2023